ABT-263 - ≥98%, high purity , CAS No.923564-51-6

  • ≥98%
Item Number
A276560
Grouped product items
SKUSizeAvailabilityPrice Qty
A276560-5mg
5mg
5
$36.90
A276560-25mg
25mg
3
$83.90
A276560-100mg
100mg
4
$187.90
A276560-500mg
500mg
1
$729.90

Potent, small molecule Bcl-2 family protein inhibitor

View related series
Apoptosis (0) Bcl-2 Family (0)

Basic Description

SynonymsNavitoclax | ABT263 | (R)-4-(4-((4'-Chloro-4,4-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)-N-((4-((4-morpholino-1-(phenylthio)butan-2-yl)amino)-3-((trifluoromethyl)sulfonyl)phenyl)sulfonyl)benzamide
Specifications & Purity≥98%
Biochemical and Physiological MechanismsPotent, small molecule Bcl-2 family protein inhibitor (Ki’s of <1 nM for Bcl-2, Bcl-XL and Bcl-w). Orally bioavailable. Displays anticancer properties. Selectively binds to apoptosis suppressor proteins Bcl-2, Bcl-XL, and Bcl-w and disrupts Bcl-2/Bcl-XL i
Storage TempStore at -20°C,Desiccated
Shipped InIce chest + Ice pads
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Refer to SDS for further information Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

Shipped at 4°C. Store at -20°C. Store under desiccating conditions.


Product description

Navitoclax (ABT-263) is a potent and orally active Bcl-2 family protein inhibitor that binds to multiple anti-apoptotic Bcl-2 family proteins, such as Bcl-xL, Bcl-2 and Bcl-w, with a Ki of less than 1 nM.

AI Insight

Product Properties

ALogP9.6

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

Pubchem Sid488200732
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/488200732
IUPAC Name 4-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide
INCHI InChI=1S/C47H55ClF3N5O6S3/c1-46(2)20-18-42(34-8-12-37(48)13-9-34)36(31-46)32-55-22-24-56(25-23-55)39-14-10-35(11-15-39)45(57)53-65(60,61)41-16-17-43(44(30-41)64(58,59)47(49,50)51)52-38(19-21-54-26-28-62-29-27-54)33-63-40-6-4-3-5-7-40/h3-17,30,38,52H,18-29,31-33H2,1-2H3,(H,53,57)/t38-/m1/s1
InChi Key JLYAXFNOILIKPP-KXQOOQHDSA-N
Canonical SMILES CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)NC(CCN5CCOCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C
Isomeric SMILES CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)N[C@H](CCN5CCOCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C
PubChem CID 24978538
Molecular Weight 974.61

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

15 results found

Lot NumberCertificate TypeDateItem
G2404133Certificate of AnalysisApr 08, 2025 A276560
G2404134Certificate of AnalysisApr 08, 2025 A276560
G2404135Certificate of AnalysisApr 08, 2025 A276560
G2404136Certificate of AnalysisApr 08, 2025 A276560
C2325098Certificate of AnalysisJan 12, 2024 A276560
C2325232Certificate of AnalysisJan 12, 2024 A276560
C2325100Certificate of AnalysisJan 12, 2024 A276560
C2325099Certificate of AnalysisJan 12, 2024 A276560
C2325097Certificate of AnalysisJan 12, 2024 A276560
C2325096Certificate of AnalysisJan 12, 2024 A276560
L2314018Certificate of AnalysisFeb 18, 2023 A276560
A2218093Certificate of AnalysisNov 14, 2022 A276560
A2218094Certificate of AnalysisDec 30, 2021 A276560
A2218207Certificate of AnalysisDec 30, 2021 A276560
A2218220Certificate of AnalysisDec 30, 2021 A276560

Show more⌵

Related Documents

Reviews

Customer Reviews

Citations of This Product

1. Yun Zhou, Ke Li, Fan Li, Shuang Han, Yang Wang, Xueping Li, Yonghua Zhan.  (2019)  Doxorubicin and ABT-199 Coencapsulated Nanocarriers for Targeted Delivery and Synergistic Treatment against Hepatocellular Carcinoma.  Journal of Nanomaterials,  2019  (5274598).  [PMID:] [10.1155/2019/5274598]

References

1. Yun Zhou, Ke Li, Fan Li, Shuang Han, Yang Wang, Xueping Li, Yonghua Zhan.  (2019)  Doxorubicin and ABT-199 Coencapsulated Nanocarriers for Targeted Delivery and Synergistic Treatment against Hepatocellular Carcinoma.  Journal of Nanomaterials,  2019  (5274598).  [PMID:] [10.1155/2019/5274598]

Solution Calculators